glp 1 agonist therapy GLP-1 Medications: Everything You Need to Know Evolution of GLP‐1 Receptor Agonists

Description

Of note, exenatide is effective in suppressing the production of chylomicrons and the rise of apoB-48 in the circulation, following administration of a lipid-containing meal directly into the small intestine in individuals without diabetes (74)

Oral formulations might enable obesity treatment to move decisively into primary care, extending its reach well beyond todays specialist base and giving access to greater numbers of patients earlier in the course of the disease

Back Klausen, MK, Jensen, ME, Mller, M, et al (6 Sept 2022) 'Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial', JCI Insight, 7/19, e159863

In subsequent Phase 2 trials, once-weekly subcutaneous injections of retatrutide at doses of 4 mg, 8 mg, and 12 mg resulted in marked improvements in glycemic control compared to placebo, along with substantial weight loss when contrasted with placebo and dulaglutide (1.5 mg)

The REWIND trial suggested that dulaglutide might be effective for both primary and secondary cardiovascular prevention in individuals with T2DM (254)